Long-term vitamin E supplementation reduces atherosclerosis and mortality in Ldlr-/- mice, but not when fed Western style diet

Atherosclerosis

Volumn 233, Issue 1, 2014, Pages 196-205

  Meydani, Mohsen ^a   Kwan, Paul ^a   Band, Michael ^a   Knight, Ashley ^a   Guo, Weimin ^a   Goutis, Jason ^a   Ordovas, Jose ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Fatty lesion; Long term supplementation; Survival; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CD36 ANTIGEN; CHOLESTEROL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA ATHEROSCLEROSIS; AORTA ROOT; AORTA VALVE; ARTERIAL WALL THICKNESS; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DIET THERAPY; HEALTH STATUS; LIPID DIET; LOW FAT DIET; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ATHEROSCLEROSIS; FATTY LESION; LDLR(-/-) MOUSE; LONG-TERM SUPPLEMENTATION; SURVIVAL; VITAMIN E;

AGING; ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DIET; DIET, HIGH-FAT; DIETARY FATS; DIETARY SUPPLEMENTS; LIPIDS; MALE; MICE; RECEPTORS, LDL; VITAMIN E;

EID: 84893822158     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.12.006     Document Type: Article

References (67)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. Thom T.J., Epstein F.H., Feldman J.J., Leaverton P.E., Wolz M. Total mortality and morbidity from heart disease, cancer, and stroke from 1950 to 1987 in 27 countries 1992, National Institutes of Health, Betesda, MD, NIH publication no.92-3088.
3. American Heart Association Heart and stroke facts: 1994 statistical supplement 1994, 1-22. American Heart Association, Dallas, TX.
4. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond Cholesterol: modifications of low density lipoprotein that increase its atherogenicity. NEngl J Med 1989, 320:915-924.
5. Pryor W.A. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000, 28:141-164.
6. Meydani M. Vitamin E and prevention of heart disease in high-risk patients. Nutr Rev 2000, 58:278-281.
7. Cyrus T., Yao Y., Rokach J., Tang L.X., Pratico D. Vitamin E reduces progression of atherosclerosis in low-density lipoprotein receptor-deficient mice with established vascular lesions. Circulation 2003, 107:521-523.
8. Pratico D., Tangirala R.K., Rader D.J., Rokach J., FitzGerald G.A. Vitamin E suppresses isoprostane generation invivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 1998, 4:1189-1192.
9. Azzi A., Gysin R., Kempna P., et al. Vitamin E mediates cell signaling and regulation of gene expression. Ann N Y Acad Sci 2004, 1031:86-95.
10. Sesso H.D., Buring J.E., Christen W.G., et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008, 300:2123-2133.
11. Hoogwerf B.J., Young J.B. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Cleve Clin J Med 2000, 67:287-293.
12. Lonn E., Bosch J., Yusuf S., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005, 293:1338-1347.
13. Marchioli R., Levantesi G., Macchia A., et al. Vitamin E increases the risk of developing heart failure after myocardial infarction: results from the GISSI-Prevenzione trial. JCardiovasc Med 2006, 7:347-350.
14. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354:447-455. GISSI-Prevenzione Investigators.
15. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:23-33. Heart protection collaborative group.
16. Chae C.U., Albert C.M., Moorthy M.V., Lee I.M., Buring J.E. Vitamin E supplementation and the risk of heart failure in women. Circ Heart Failure 2012, 5:176-182.
17. Suarna C., Wu B.J., Choy K., et al. Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency. Free Radic Biol Med 2006, 41:722-730.
18. Shirpoor A., Norouzi L., Khadem Ansari M.H., Ilkhanizadeh B., Gharaaghaji R. Vasoprotective effect of vitamin E: rescue of ethanol-induced atherosclerosis and inflammatory stress in rat vascular wall. Int Immunopharmacol 2013, 16:498-504.
19. Goldenstein H., Levy N.S., Lipener Y.T., Levy A.P. Patient selection and vitamin E treatment in diabetes mellitus. Exp Rev Cardiovasc Ther 2013, 11:319-326.
20. Farbstein D., Blum S., Pollak M., et al. Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype. Atherosclerosis 2011, 219:240-244.
21. Milman U., Blum S., Shapira C., et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol 2008, 28:341-347.
22. Van Horn L. Fiber, lipids, and coronary heart disease. A statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997, 95:2701-2704.
23. McGill H.C.J., McMahan C.A., Zieske A.W., et al. Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol 2000, 20:1998-2004.
24. Burke G.L., Cresanta J.L., Shear C.L., Miner M.H., Berenson G.S. Cardiovascular risk factors and their modification in children. Cardiol Clin 1986, 4:33-46.
25. Giannini C., de Giorgis T., Scarinci A., et al. Increased carotid intima-media thickness in pre-pubertal children with constitutional leanness and severe obesity: the speculative role of insulin sensitivity, oxidant status, and chronic inflammation. Eur J Endocrinol 2009, 161:73-80.
26. Bekkers M.B., Brunekreef B., Smit H.A., et al. Early-life determinants of total and HDL cholesterol concentrations in 8-year-old children; the PIAMA Birth Cohort Study. PLoS One 2011, 6:e25533.
27. Bao W., Srinivasan S., Valdez R., Greenlund K., Wattigney W., Berenson G. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. JAMA 1997, 278:1749-1754.
28. Napoli C., Glass C., Witztum J.L., Deutsch R., D'Armiento F.P., Palinski W. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet 1999, 354:1234-1241.
29. Napoli C., Witztum J.L., Calara F., de Nigris F., Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy. An experimental model of atherogenic mechanisms in human fetuses. Circ Res 2000, 87:946-952.
30. Juonala M., Magnussen C.G., Venn A., et al. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation 2010, 122:2514-2520.
31. Walsh P.C. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JUrol 2005, 174:1823-1824.
32. Gidding S.S., Dennison B.A., Birch L.L., et al. Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation 2005, 112:2061-2075.
33. Lichtenstein A.H., Appel L.J., Brands M., et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006, 114:82-96.
34. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus mediated gene delivery. JClin Invest 1993, 92:883-893.
35. Smith J.D., Breslow J.L. The emergence of mouse models of atherosclerosis and their relevance to clinical research. JIntern Med 1997, 242:99-109.
36. Lichtman A.H., Clinton S.K., Iiyama K., Connelly P.W., Libby P., Cybulsky M.I. Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. Artherioscler Thromb Vasc Biol 1999, 19:1938-1944.
37. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee in the reformulation of the AIN-76A rodent diet. JNutr 1993, 123:1939-1951.
38. A report of the Panel on Dietary Antioxidants and Related Compounds Vitamin E. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids 2000, 186-283. National Academy Press, Washington, D.C.
39. Palinski W., Tangirala R.K., Miller E., Young S.G., Witztum J.L. Increased autoantibody titers against epitopes of oxidised LDL in LDL receptor-deficient mice with increased atherosclerosis. Artherioscler Thromb Vasc Biol 1995, 15:1569-1576.
40. Tangirala R.K., Pratico D., FitzGerald G.A., et al. Reduction of isoprostanes and regression of advanced atherosclerosis by apolipoprotein E. JBiol Chem 2001, 276:261-266.
41. Guo W., Wise M.L., Collins F.W., Meydani M. Avenanthramides, polyphenols from oats, inhibit IL-1beta-induced NF-kappaB activation in endothelial cells. Free Radic Biol Med 2008, 44:415-429.
42. Rodriguez S.K., Guo W., Liu L., Band M.A., Paulson E.K., Meydani M. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer 2006, 118:1635-1644.
43. McNamara J.R., Schaefer E.J. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chem Acta 1987, 166:1-8.
44. Meydani M., Evans W.J., Handelman G., et al. Protective effect of vitamin E on exercise-induced oxidative damage in young and older adults. Am J Physiol 1993, 33:R992-R998.
45. Crawford R.S., Kirk E., Rosenfeld M.E., LeBoeuf R.C., Chait A. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse. Artherioscl Thromb Vasc Biol 1998, 18:1506-1513.
46. Navarro A., Gomez C., Sanchez-Pino M.-J., et al. Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. Am J Physiol Regul Integr Comp Physiol 2005, 289:R1392-R1399.
47. Ejaz A., Wu D., Kwan P., Meydani M. Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. JNutr 2009, 139:919-925.
48. Bruell J.H., Daroczy A.F., Hellerstein H.K. Strain and sex differences in serum cholesterol levels of mice. Science 1962, 135:1071-1072.
49. Prasad K., McNair E.D., Qureshi A.M., Casper-Bell G. Vitamin E slows the progression of hypercholesterolemia-induced oxidative stress in heart, liver and kidney. Mol Cell Biochem 2012, 368:181-187.
50. Abbas A.M., Sakr H.F. Simvastatin and vitamin E effects on cardiac and hepatic oxidative stress in rats fed on high fat diet. JPhysiol Biochem 2013, 69:737-750.
51. Huang Z.G., Liang C., Han S.F., Wu Z.G. Vitamin E ameliorates ox-LDL-induced foam cells formation through modulating the activities of oxidative stress-induced NF-kappaB pathway. Mol Cell Biochem 2012, 363:11-19.
52. Devaraj S., Tang R., Adams-Huet B., et al. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr 2007, 86:1392-1398.
53. Koga T., Claycombe K., Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 2002, 161:365-374.
54. Koga T., Kwan P., Zubik L., Ameho C., Smith D., Meydani M. Vitamin E supplementation suppresses macrophage accumulation and endothelial cell expression of adhesion molecules in the aorta of hypercholesterolemic rabbits. Atherosclerosis 2004, 176:265-272.
55. Hasty A.H., Gruen M.L., Terry E.S., et al. Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model. JNutr Biochem 2007, 18:127-133.
56. Singh U., Devaraj S., Jialal I. Vitamin E, oxidative stress, and inflammation. Annu Rev Nutr 2005, 25:151-174.
57. Guyton A.C. Textbook of medical physiology 1971, WB Saunders Company.
58. Meydani M., Meydani S.N., Blumberg J.B. Modulation by dietary vitamin E and selenium of clotting whole blood thromboxane A2 and aortic prostacyclin synthesis in rats. Nutr Biochem 1993, 4:322-326.
59. Baldi S., Innocenti M., Frascerra S., et al. Effects of hemodialysis and vitamin E supplementation on low-density lipoprotein oxidizability in end-stage renal failure. JNephrol 2013, 26:549-555.
60. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
61. Stoll G., Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke J Cerebr Circ 2006, 37:1923-1932.
62. Kawai Y., Tanaka H., Murota K., Naito M., Terao J. (-)-Epicatechin gallate accumulates in foamy macrophages in human atherosclerotic aorta: implication in the anti-atherosclerotic actions of tea catechins. Biochem Biophys Res Commun 2008, 374:527-532.
63. Ricciarelli R., Z.J., Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000, 82-87.
64. Lecompte S., Szabo de Edelenyi F., Goumidi L., et al. Polymorphisms in the CD36/FAT gene are associated with plasma vitamin E concentrations in humans. Am J Clin Nutr 2011, 93:644-651.
65. Murphy N., Grimsditch D.C., Vidgeon-Hart M., et al. Dietary antioxidants decrease serum soluble adhesion molecule (sVCAM-1, sICAM-1) but not chemokine (JE/MCP-1, KC) concentrations, and reduce atherosclerosis in C57BL but not apoE*3 Leiden mice fed an atherogenic diet. Dis Markers 2005, 21:181-190.
66. Peluzio M.C., Miguel E., Drumond T.C., et al. Monocyte chemoattractant protein-1 involvement in the alpha-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice. Br J Nutr 2003, 90:3-11.
67. Rayment S.J., Shaw J., Woollard K.J., Lunec J., Griffiths H.R. Vitamin C supplementation in normal subjects reduces constitutive ICAM-1 expression. Biochem Biophys Res Commun 2003, 308:339-345.